{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:54:25Z","timestamp":1784951665186,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1124\/jpet.123.001583","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T22:15:38Z","timestamp":1698185738000},"page":"288-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma"],"prefix":"10.1016","volume":"387","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-5400","authenticated-orcid":false,"given":"Linyan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongshen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001583_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.456","article-title":"Reactivation of Epstein-Barr virus from latency","volume":"15","author":"Amon","year":"2005","journal-title":"Rev Med Virol"},{"key":"10.1124\/jpet.123.001583_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2011.08.015","article-title":"Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication","volume":"10","author":"Andrei","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1124\/jpet.123.001583_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","article-title":"ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence","volume":"277","author":"Cagnol","year":"2010","journal-title":"FEBS J"},{"key":"10.1124\/jpet.123.001583_bib4","article-title":"Recent Update of HDAC Inhibitors in Lymphoma","volume":"8","author":"Chen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1124\/jpet.123.001583_bib5","doi-asserted-by":"crossref","first-page":"9635","DOI":"10.1128\/JVI.79.15.9635-9650.2005","article-title":"Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus","volume":"79","author":"Chen","year":"2005","journal-title":"J Virol"},{"key":"10.1124\/jpet.123.001583_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1158\/1055-9965.EPI-19-0551","article-title":"The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma","volume":"29","author":"Coghill","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1124\/jpet.123.001583_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/14760584.2019.1605906","article-title":"Prophylactic and therapeutic strategies for Epstein-Barr virus-associated diseases: emerging strategies for clinical development","volume":"18","author":"Dasari","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1124\/jpet.123.001583_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s11010-022-04554-6","article-title":"Chidamide works synergistically with Dasatinib by inducing cell-cycle arrest and apoptosis in acute myeloid leukemia cells","volume":"478","author":"Deng","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/jpet.123.001583_bib9","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.1073\/pnas.2002392117","article-title":"Tenofovir prodrugs potently inhibit Epstein-Barr virus lytic DNA replication by targeting the viral DNA polymerase","volume":"117","author":"Drosu","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.001583_bib10","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00432-020-03269-9","article-title":"Correction to: Sequential anti-CD19, 22, and 20 autologous chimeric antigen receptor T-cell (CAR-T) treatments of a child with relapsed refractory Burkitt lymphoma: a case report and literature review","volume":"146","author":"Du","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1124\/jpet.123.001583_bib11","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.1038\/s41598-020-66153-z","article-title":"Identifying the role of PrimPol in TDF-induced toxicity and implications of its loss of function mutation in an HIV+ patient","volume":"10","author":"Duong","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.123.001583_bib12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2174\/1871520616666160901150427","article-title":"Preclinical and Clinical Studies of Chidamide (CS055\/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy","volume":"17","author":"Gao","year":"2017","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1124\/jpet.123.001583_bib13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood-2011-06-362434","article-title":"Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents","volume":"119","author":"Ghosh","year":"2012","journal-title":"Blood"},{"key":"10.1124\/jpet.123.001583_bib14","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1158\/1078-0432.CCR-12-2537","article-title":"hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies","volume":"19","author":"Giunco","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.123.001583_bib15","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1124\/jpet.123.001583_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1186\/s12885-016-2807-y","article-title":"The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways","volume":"16","author":"Hrgovic","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1124\/jpet.123.001583_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ijc.29698","article-title":"Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir","volume":"138","author":"Hui","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1124\/jpet.123.001583_bib18","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/ijc.24945","article-title":"Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death","volume":"126","author":"Hui","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1124\/jpet.123.001583_bib19","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/ijc.27439","article-title":"Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma","volume":"131","author":"Hui","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1124\/jpet.123.001583_bib20","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1111\/j.1751-553X.2008.01130.x","article-title":"Sodium valproate in combination with ganciclovir induces lysis of EBV-infected lymphoma cells without impairing EBV-specific T-cell immunity","volume":"32","author":"Jones","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"10.1124\/jpet.123.001583_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","article-title":"Lymphoid neoplasms associated with concurrent t(14;18) and 8q24\/c-MYC translocation generally have a poor prognosis","volume":"19","author":"Kanungo","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1124\/jpet.123.001583_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jclinpath-2019-205822","article-title":"Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors","volume":"72","author":"Kerr","year":"2019","journal-title":"J Clin Pathol"},{"key":"10.1124\/jpet.123.001583_bib23","doi-asserted-by":"crossref","first-page":"15104","DOI":"10.1074\/jbc.RA119.008193","article-title":"Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription","volume":"294","author":"Kusano","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.123.001583_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1442-2042.2006.01344.x","article-title":"Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest","volume":"13","author":"Li","year":"2006","journal-title":"Int J Urol"},{"key":"10.1124\/jpet.123.001583_bib25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2010.01.011","article-title":"A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells","volume":"392","author":"Liu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.123.001583_bib26","first-page":"193","article-title":"Chidamide and 5-flurouracil show a synergistic antitumor effect on human colon cancer xenografts in nude mice","volume":"63","author":"Liu","year":"2016","journal-title":"Neoplasma"},{"key":"10.1124\/jpet.123.001583_bib27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.biopha.2016.08.023","article-title":"A novel histone deacetylase inhibitor Chidamide induces G0\/G1 arrest and apoptosis in myelodysplastic syndromes","volume":"83","author":"Liu","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1124\/jpet.123.001583_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-022-00404-3","article-title":"Burkitt lymphoma","volume":"8","author":"L\u00f3pez","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1124\/jpet.123.001583_bib29","first-page":"237","article-title":"Epstein-Barr Virus Lytic Cycle Reactivation","volume":"391","author":"McKenzie","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1124\/jpet.123.001583_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-981-10-7230-7_18","article-title":"Encyclopedia of EBV-Encoded Lytic Genes: An Update","volume":"1045","author":"Murata","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/jpet.123.001583_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00589-20","article-title":"Epstein-Barr Virus LMP1 Promotes Syntenin-1- and Hrs-Induced Extracellular Vesicle Formation for Its Own Secretion To Increase Cell Proliferation and Migration","volume":"11","author":"Nkosi","year":"2020","journal-title":"MBio"},{"key":"10.1124\/jpet.123.001583_bib32","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/jmv.24870","article-title":"Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model","volume":"89","author":"Novali\u0107","year":"2017","journal-title":"J Med Virol"},{"key":"10.1124\/jpet.123.001583_bib33","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/cas.12812","article-title":"Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma","volume":"106","author":"Okamoto","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1124\/jpet.123.001583_bib34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ajh.25010","article-title":"A phase I\/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806","volume":"93","author":"Persky","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1124\/jpet.123.001583_bib35","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3109\/10428194.2015.1135431","article-title":"A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520","volume":"57","author":"Puvvada","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1124\/jpet.123.001583_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01070-19","article-title":"The Epstein-Barr Virus BMRF1 Protein Activates Transcription and Inhibits the DNA Damage Response by Binding NuRD","volume":"93","author":"Salamun","year":"2019","journal-title":"J Virol"},{"key":"10.1124\/jpet.123.001583_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ijc.33802","article-title":"Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group","volume":"150","author":"Shen","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1124\/jpet.123.001583_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2015.03.016","article-title":"Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma","volume":"364","author":"Shin","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1124\/jpet.123.001583_bib39","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s10120-021-01193-6","article-title":"EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer","volume":"24","author":"Soldan","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1124\/jpet.123.001583_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hon.2954","article-title":"Synergistic anticancer effect of a combination of chidamide and etoposide against NK\/T cell lymphoma","volume":"41","author":"Song","year":"2023","journal-title":"Hematol Oncol"},{"key":"10.1124\/jpet.123.001583_bib41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/bjh.13195","article-title":"Phase I\/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation","volume":"168","author":"Straus","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1124\/jpet.123.001583_bib42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2013.11.019","article-title":"p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents","volume":"344","author":"Sui","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1124\/jpet.123.001583_bib43","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.3892\/or.2015.4305","article-title":"LMP1 promotes nasal NK\/T-cell lymphoma cell function by eIF4E via NF-\u03baB pathway","volume":"34","author":"Sun","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1124\/jpet.123.001583_bib44","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1124\/jpet.123.001583_bib45","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.2174\/092986707782023299","article-title":"Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis","volume":"14","author":"Takai","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.123.001583_bib46","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/blood.2019000928","article-title":"Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection","volume":"135","author":"Tangye","year":"2020","journal-title":"Blood"},{"key":"10.1124\/jpet.123.001583_bib47","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.bmcl.2019.06.034","article-title":"Development of a novel inducer for EBV lytic therapy","volume":"29","author":"Tikhmyanova","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.123.001583_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12981-021-00380-w","article-title":"Tenofovir alafenamide nephrotoxicity: a case report and literature review","volume":"18","author":"Ueaphongsukkit","year":"2021","journal-title":"AIDS Res Ther"},{"key":"10.1124\/jpet.123.001583_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02243-21","article-title":"The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells","volume":"12","author":"Westhoff Smith","year":"2021","journal-title":"MBio"},{"key":"10.1124\/jpet.123.001583_bib50","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/JVI.01790-12","article-title":"Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication","volume":"87","author":"Wille","year":"2013","journal-title":"J Virol"},{"key":"10.1124\/jpet.123.001583_bib51","first-page":"1124","article-title":"Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy","volume":"135","author":"Woessmann","year":"2020","journal-title":"Blood"},{"key":"10.1124\/jpet.123.001583_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00432-015-2026-y","article-title":"Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents","volume":"142","author":"Xue","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1124\/jpet.123.001583_bib53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13148-019-0723-0","article-title":"Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair","volume":"11","author":"Ye","year":"2019","journal-title":"Clin Epigenetics"},{"key":"10.1124\/jpet.123.001583_bib54","first-page":"411","article-title":"Chidamide, a histone deacetylase inhibitor, induces growth arrest and apoptosis in multiple myeloma cells in a caspase-dependent manner","volume":"18","author":"Yuan","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1124\/jpet.123.001583_bib55","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/ijms21072346","article-title":"Understanding MAPK Signaling Pathways in Apoptosis","volume":"21","author":"Yue","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.123.001583_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0168-1702(92)90154-2","article-title":"Transcriptional expression of the viral genome in the Epstein-Barr virus-induced tamarin lymphoma and the corresponding lymphoblastoid tumour lines","volume":"26","author":"Zhang","year":"1992","journal-title":"Virus Res"},{"key":"10.1124\/jpet.123.001583_bib57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3892\/mmr.2021.11947","article-title":"Chidamide induces apoptosis in DLBCL cells by suppressing the HDACs\/STAT3\/Bcl-2 pathway","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol Med Rep"},{"key":"10.1124\/jpet.123.001583_bib58","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.2147\/OTT.S240721","article-title":"The Synergistic Antitumor Activity of Chidamide in Combination with Bortezomib on Gastric Cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"OncoTargets Ther"},{"key":"10.1124\/jpet.123.001583_bib59","first-page":"3169","article-title":"Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2\/STAT3 signaling","volume":"8","author":"Zhao","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1124\/jpet.123.001583_bib60","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10637-017-0552-y","article-title":"Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK\/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway","volume":"36","author":"Zhou","year":"2018","journal-title":"Invest New Drugs"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:32:06Z","timestamp":1739971926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524171212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0022356524171212"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001583","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}